Skip to main content

Table 2 Outcomes of NHGC participants at last clinic visit

From: Cohort profile: the Nigerian HIV geriatric cohort study

Outcome All participants
N = 101,652
ART Regimen
ART regimen line at last visit, n(%)
 First line 97,586 (96%)
 Second Line 4066 (4%)
Current ART regimen at last visit, n(%)
 ABC-Based 3050 (3%)
 AZT-Based 29,479 (29%)
 TDF-Based 66,125 (65%)
 Others 2998 (3%)
Number of years on ART treatment, median (IQR) 4.1 (1.7–7.1)
Number of years on ART treatment, n(%)
  < 2 29,225 (29%)
 2 - < 5 31,095 (31%)
 5 - < 10 31,512 (32%)
 10 and above 9819 (10%)
Viral Loada
Viral load at last measurement, copies/ml, n(%)
  < 1000 26,687 (82%)
Participant status
Status at last visit, n(%)
 Active in care 62,821 (62%)
 Died 6912 (7%)
 Lost to follow-up 28,463 (28%)
 Stopped/Transferred Out 3456 (3%)
  1. Results are number and percent of those with non-missing data; aOnly 38,199 (38%) had a viral measurement within one year of their last visit
  2. ART Antiretroviral Therapy, ABC Abacavir, AZT Zidovudine, TDF Tenofovir Disoproxil Fumarate